169 related articles for article (PubMed ID: 9125797)
1. Treatment of lupus nephritis.
Austin HA; Boumpas DT
Semin Nephrol; 1996 Nov; 16(6):527-35. PubMed ID: 9125797
[TBL] [Abstract][Full Text] [Related]
2. Natural history and treatment of lupus nephritis.
Austin HA; Balow JE
Semin Nephrol; 1999 Jan; 19(1):2-11. PubMed ID: 9952276
[TBL] [Abstract][Full Text] [Related]
3. [Lupus nephritis: retrospective analysis of the course of the disease].
Djukanović L; Pavlović S; Blagojević R; Dimitrijević J; Stojsic T; Ratković M; Kazić K; Lezaić V; Naumović R
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
[TBL] [Abstract][Full Text] [Related]
4. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[TBL] [Abstract][Full Text] [Related]
6. Treatment of lupus nephritis.
Austin HA; Balow JE
Semin Nephrol; 2000 May; 20(3):265-76. PubMed ID: 10855936
[TBL] [Abstract][Full Text] [Related]
7. Beyond immunosuppression - challenges in the clinical management of lupus nephritis.
Masood S; Jayne D; Karim Y
Lupus; 2009 Feb; 18(2):106-15. PubMed ID: 19151111
[TBL] [Abstract][Full Text] [Related]
8. Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions.
Ortega LM; Schultz DR; Lenz O; Pardo V; Contreras GN
Lupus; 2010 Apr; 19(5):557-74. PubMed ID: 20089610
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure.
Faurschou M; Starklint H; Halberg P; Jacobsen S
J Rheumatol; 2006 Aug; 33(8):1563-9. PubMed ID: 16881113
[TBL] [Abstract][Full Text] [Related]
10. [Lupus nephritis--clinical and morfological correlation].
Banković N; Blagojević R; Jovanović D; Sindjić M; Pavlović S; Stojković D; Djukanović Lj
Srp Arh Celok Lek; 1994; 122(7-8):215-7. PubMed ID: 17974390
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic options for resistant lupus nephritis.
Mok CC
Semin Arthritis Rheum; 2006 Oct; 36(2):71-81. PubMed ID: 16884971
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of diffuse proliferative lupus nephritis.
Lim CS; Chin HJ; Jung YC; Kim YS; Ahn C; Han JS; Kim S; Lee JS
Clin Nephrol; 1999 Sep; 52(3):139-47. PubMed ID: 10499308
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in diffuse proliferative lupus nephritis.
Abraham MA; Korula A; Jayakrishnan K; John GT; Thomas PP; Jacob CK
J Assoc Physicians India; 1999 Sep; 47(9):862-5. PubMed ID: 10778652
[TBL] [Abstract][Full Text] [Related]
14. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[TBL] [Abstract][Full Text] [Related]
15. [Clinical course and prognostic factors in lupus nephropathy].
Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
[TBL] [Abstract][Full Text] [Related]
16. Lupus nephritis.
Sauter M; Anders HJ
Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686
[TBL] [Abstract][Full Text] [Related]
17. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis.
Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Li PK; Szeto CC
Nephrol Dial Transplant; 2006 Jun; 21(6):1534-40. PubMed ID: 16449281
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy.
Kanno A; Hotta O; Yusa N; Taguma Y
Ren Fail; 2007; 29(1):41-7. PubMed ID: 17365909
[TBL] [Abstract][Full Text] [Related]
19. Lupus membranous glomerulonephritis: different prognostic subgroups obscured by imprecise histologic classifications.
Adler SG; Johnson K; Louie JS; Liebling MR; Cohen AH
Mod Pathol; 1990 Mar; 3(2):186-91. PubMed ID: 2326250
[TBL] [Abstract][Full Text] [Related]
20. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
